Janssen Booster Evidence Draws Questions From US FDA, But Also A Nod Towards Benefits
The FDA's Vaccines and Related Biological Products Advisory Committee will consider whether a Janssen COVID-19 vaccine booster should be recommended. • Source: Alamy
